AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023

Marc Thill*, Cornelia Kolberg-Liedtke, Ute Susann Albert, Maggie Banys-Paluchowski, Ingo Bauerfeind, Jens Uwe Blohmer, Wilfried Budach, Peter Dall, Nina Ditsch, Eva Maria Fallenberg, Peter A. Fasching, Tanja Fehm, Michael Friedrich, Bernd Gerber, Oleg Gluz, Nadia Harbeck, Andreas D. Hartkopf, Joerg Heil, Jens Huober, Christian JackischHans H. Kreipe, David Krug, Thorsten Kühn, Sherko Kümmel, Sibylle Loibl, Diana Lüftner, Michael Patrick Lux, Nicolai Maass, Christoph Mundhenke, Toralf Reimer, Kerstin Rhiem, Achim Rody, Marcus Schmidt, Andreas Schneeweiss, Florian Schütz, Hans Peter Sinn, Christine Solbach, Erich Franz Solomayer, Elmar Stickeler, Christoph Thomssen, Michael Untch, Isabell Witzel, Achim Wöckel, Rachel Wuerstlein, Volkmar Müller, Wolfgang Janni, Tjoung Won Park-Simon

*Corresponding author for this work
2 Citations (Scopus)


The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) presents the 2023 update of the evidence-based recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer (mBC).

Original languageEnglish
JournalBreast Care
Issue number4
Pages (from-to)305-314
Number of pages10
Publication statusPublished - 01.08.2023

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)
  • Centers: University Cancer Center Schleswig-Holstein (UCCSH)

DFG Research Classification Scheme

  • 205-14 Haematology, Oncology
  • 205-21 Gynaecology and Obstetrics

Cite this